FDA Investigates Cancer Risk with Zolgensma Gene Therapy

by Devices and Pharma | Nov 9, 2026 | Alerts - Gene Therapy, Gene Therapy, Industry Information, Industry News, US-FDA

FDA Investigates Cancer Risk with Zolgensma Gene Therapy Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary AI Quality QMSR Central News Enforcement Alerts...

FDA Approves Treatment for Advanced Head and Neck Cancer

by Devices and Pharma | Nov 6, 2026 | Biologics-information, FDA Approvals, Industry Information, Industry News, New Biologics, Products_biologics, Reg_Products, US-FDA

FDA Approves Treatment for Advanced Head and Neck Cancer Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary AI Quality QMSR Central News Enforcement Alerts...

FDA Approves Treatment that Targets SMA Muscle Loss

by Devices and Pharma | Nov 6, 2026 | Biologics-information, FDA Approvals, Monoclonal Antibody, Products_biologics, US-FDA

FDA Approves Treatment that Targets SMA Muscle Loss Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary AI Quality QMSR Central News Enforcement Alerts...

FDA Cell and Gene Therapy Potency Guidance

by Devices and Pharma | Nov 4, 2026 | Cell Therapy, Gene Therapy, Gene Therapy, Guidance Documents, Industry Information, Industry News

FDA Cell and Gene Therapy Potency Guidance Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary AI Quality QMSR Central News Enforcement Alerts Innovation...

Final Guidance on Potency Assurance for Cell and Gene Therapies

by Devices and Pharma | Nov 4, 2026 | Cell Therapy, Gene Therapy, Gene Therapy, Guidance Documents, Industry Information, Industry News

Final Guidance on Potency Assurance for Cell and Gene Therapies Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary AI Quality QMSR Central News Enforcement...

FDA Approves Voceryq, First Plasmid DNA Immunotherapy

by Devices and Pharma | Nov 2, 2026 | Biologics-information, New Biologics

FDA Approves Voceryq, First Plasmid DNA Immunotherapy Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary AI Quality QMSR Central News Enforcement Alerts...